Study casts doubt on WHO guidance on antibiotics for neonatal sepsis umn.edu - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from umn.edu Daily Mail and Mail on Sunday newspapers.
Feb 08 2021 Read 472 Times
An institute for antimicrobial research is to open at Oxford University following a £100 million donation from Ineos, one of the world’s largest chemical manufacturing companies. Antimicrobial resistance (AMR) has been estimated to cause 1.5 million excess deaths each year, with associated projections reaching 10m deaths per year by 2050 and it is arguably the greatest economic and healthcare challenge facing the world post-Covid.
As the majority of global antibiotic consumption by volume is used for agriculture, the IOI will focus on designing novel antimicrobials just for animals, as well as exploring new human drugs. With aims to create partnerships with other global leaders in AMR, the Ineos Oxford Institute for Antimicrobial Research (IOI) critically will seek to attract and train the brightest minds in science to tackle this ‘silent pandemic’.
An announcement from Oxford signals that it is still very much the go-to university if you’re a tax-averse billionaire, eager for serious recognition but concerned that academic sensibilities might somehow come between your £100m and a place alongside Duke Humfrey, Godfrey Sheldon and more recent donors Wafic Said and Leonard Blavatnik. Other than welcoming its latest big benefactor, Sir Jim Ratcliffe, on a day likely to be eclipsed by the.
£100m donation to help develop novel livestock antibiotics
21 January 2021 |
Researchers want to develop new drugs for livestock, as well as promote responsible use of the antibiotics
A £100 million donation has been made to help establish a new initiative which seeks to develop bespoke antibiotics for livestock.
Ineos, a UK-based multinational chemicals company, has donated the huge sum to the Ineos Oxford University Institute (IOI) for antimicrobial research.
The institute said it would focus on designing novel antimicrobials just for livestock, as well as exploring new human drugs.
It said the majority of global antibiotic consumption by volume was used for agriculture, and drug use in animals was contributing significantly to their lessening effectiveness in humans.